What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
The scientist’s investigation covers issues in Pathology, Lymphoma, Internal medicine, Immunology and Surgery.
His research in Pathology intersects with topics in T cell, Immunophenotyping and Follicular dendritic cells.
His specific area of interest is Lymphoma, where Paul J. Kurtin studies Diffuse large B-cell lymphoma.
His Internal medicine research is multidisciplinary, incorporating perspectives in Temsirolimus and Oncology.
In Immunology, Paul J. Kurtin works on issues like Natural killer cell, which are connected to Gene rearrangement, Tumor microenvironment and T-Cell/Histiocyte-Rich Large B-Cell Lymphoma.
His Surgery research incorporates themes from Disease and Muscle cramp.
His most cited work include:
- The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma (694 citations)
- Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response (650 citations)
- Lymphoid Neogenesis in Rheumatoid Synovitis (597 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Pathology, Lymphoma, Internal medicine, Amyloidosis and Biopsy.
His Pathology research includes themes of Immunoglobulin light chain, Immunophenotyping and Immunology.
His Lymphoma study incorporates themes from Peripheral T-cell lymphoma, Cancer research and Chromosomal translocation.
His biological study spans a wide range of topics, including Gastroenterology, Surgery and Oncology.
The concepts of his Amyloidosis study are interwoven with issues in AL amyloidosis, Immunoglobulin Light-chain Amyloidosis, Amyloid, Molecular biology and Renal biopsy.
His Biopsy research is multidisciplinary, relying on both Kidney and Lymph node.
He most often published in these fields:
- Pathology (57.14%)
- Lymphoma (37.59%)
- Internal medicine (25.19%)
What were the highlights of his more recent work (between 2013-2021)?
- Pathology (57.14%)
- Amyloidosis (15.79%)
- Amyloid (11.28%)
In recent papers he was focusing on the following fields of study:
Paul J. Kurtin focuses on Pathology, Amyloidosis, Amyloid, Internal medicine and Biopsy.
His studies in Pathology integrate themes in fields like Immunofluorescence, Kidney and Kidney disease.
His research in Internal medicine intersects with topics in Gastroenterology, Surgery and Oncology.
His research on Surgery often connects related areas such as Lymphoma.
His Lymphoma research is multidisciplinary, incorporating elements of Germinal center, Large cell, Chromosomal translocation and Tumor board.
His Biopsy study combines topics from a wide range of disciplines, such as Biomarker and Multiple myeloma.
Between 2013 and 2021, his most popular works were:
- Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy (174 citations)
- Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics (85 citations)
- Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma (62 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Paul J. Kurtin mainly focuses on Pathology, Amyloidosis, Amyloid, Renal biopsy and AL amyloidosis.
His Pathology research includes elements of Immunofluorescence and Laser capture microdissection.
His Amyloidosis study integrates concerns from other disciplines, such as Fibrillary Glomerulonephritis, Proteome, Immunoglobulin light chain and Immunoglobulin Light-chain Amyloidosis.
The various areas that Paul J. Kurtin examines in his Immunoglobulin light chain study include Tropism, Tissue tropism and Bone marrow.
His studies in Amyloid integrate themes in fields like Molecular biology, Transthyretin and Kidney disease.
His AL amyloidosis study combines topics in areas such as Incidence, Pediatrics and Medical record.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
